Press Releases from Dyslipidemia Drugs Market (1 total)
Dyslipidemia Drugs Market Expected to Reach USD 6.9 Billion Globally in 2023 - G …
ResearchMoz added Latest Research Report titled " Dyslipidemia Drugs Market: (By Drug Class - Statins, Bile Acid Resins, Fibric Acid and Omega-3 Fatty Acid Derivatives, Niacins, Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 " to it's Large Report database.
Dyslipidemia is a chronic metabolic syndrome, characterized by improper level of low density lipoprotein, high density lipoprotein, and triglycerides. This study on the dyslipidemia drugs…
